基于Warburg效应调控巨噬细胞NLRP3炎症小体活化探讨补阳还五汤抗动脉粥样硬化的作用机制
批准号:
82074211
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
姜希娟
依托单位:
学科分类:
中西医结合临床基础
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
姜希娟
中文摘要
巨噬细胞的胞质内感受器“NLRP3炎症小体”活化,介导并放大动脉粥样硬化(AS)炎症反应,加速AS进程。鉴于糖代谢重编程引起的“Warburg效应”促进NLRP3炎症小体活化,调控糖代谢成为抑制炎症以延缓AS的新思路。中医学认为气虚血瘀是AS主要病机,前期研究证实益气活血方药“补阳还五汤”可抑制NLRP3炎症小体活化、调控糖代谢,但其调控糖代谢与抑制炎症反应之间是否存在关联尚待进一步阐释。故提出假说:基于调控糖代谢Warburg效应抑制巨噬细胞NLRP3炎症小体活化,是补阳还五汤抗AS的潜在机制。以ApoE-/-小鼠AS模型、ox-LDL激活的巨噬细胞为研究对象,通过代谢组学、液相芯片、基因沉默/过表达等技术,在体明确该方抑制NLRP3炎性小体活化与调控Warburg效应之间的相关性,离体阐释其具体作用靶点。本研究结果可进一步丰富益气活血的理论内涵,所涉及信号蛋白有望成为抗AS的重要靶点。
英文摘要
Atherosclerosis (AS) is an inflammatory pathological process that closely associates with NLRP3 inflammasome activation in macrophages. It was shown that the “Warburg effect”, which is used by some cancer cells to reprogram glucose metabolism under aerobic conditions to apply glycolysis rather than oxidative phosphorylation, is involved in multiple steps of NLRP3 inflammasome activation. This indicates that regulating glucose metabolism could potentially block the inflammatory process in AS. Traditional Chinese Medicine (TCM) attributes AS to “Qi deficiency and blood stasis”. Therefore,“Bu Yang Huan Wu decoction”, which is a classical representative formulary of “Enriching qi and activating blood”, is demonstrated to be able to inhibit NLRP3 inflammasome activation and to alleviate lactic acidosis in our preliminary study. However, whether its effects on NLRP3 inflammasome are due to its role in glucose metabolism is still to be elucidated. So, we propose that the beneficial effect of Bu Yang Huan Wu decoction in treating AS might be through regulating the Warburg effect to inhibit NLRP3 activation in Macrophages. To explore the mechanism of Bu Yang Huan Wu decoction in treating AS and its target in regulating Warburg effect and inhibit NLRP3 inflmmasome, analytical tools include metabonomics, suspension array, gene knock out and over expressions will be applied using apoE-/- mice and ox-LDL activated macrophages as in vivo and in vitro models respectively. This project is to provide scientific evidence to the concept of “Enriching qi and activating blood” and the proteins being identified in the signal pathway of this study could be used as targets to treat AS in the future.
前期研究发现益气活血代表方补阳还五汤具有抑制NLRP3炎症小体激活而抗动脉粥样硬化(AS)的作用。但是,补阳还五汤抑制NLRP3炎症小体激活的作用是否与调控细胞代谢有关尚未可知。本项目在前期研究基础上,进一步阐明补阳还五汤是否具有抑制AS斑块和抑制巨噬细胞NLRP3炎症小体激活的作用;采用靶向代谢组学挖掘补阳还五汤调控的候选代谢产物,在体与离体相结合,筛选、验证与抑制巨噬细胞NLRP3炎症小体激活相关的关键代谢产物。结果显示,补阳还五汤可抑制AS小鼠斑块形成并减少巨噬细胞浸润,且其抗动脉粥样硬化的作用可能独立于调脂之外。进一步研究发现,补阳还五汤可抑制NLRP3炎症小体激活,下调AS小鼠主动脉NLRP3、Caspase-1及IL-1βmRNA的表达及NLRP3、pro-Caspase-1、Caspase-1、IL-1β、pro-IL-18、IL-18及ASC的蛋白表达,抑制NLRP3炎症小体的预激活和活化,但无明显剂量依赖关系。通过NLRP3与巨噬细胞标记物MOMA2免疫荧光双染可见主动脉根部斑块内NLRP3蛋白表达与巨噬细胞有较好的共定位,且补阳还五汤可抑制斑块内巨噬细胞NLRP3的活化,提示补阳还五汤抑制炎症小体活化的靶细胞主要为AS的基本细胞成分巨噬细胞。离体研究显示结果表明补阳还五汤含药血清可抑制LPS和ox-LDL诱导的巨噬细胞NLRP3炎症小体的预激活以及活化,且以补阳还五汤高剂量含药血清效果更佳。靶向代谢组学检测得到补阳还五汤抗AS相关代谢产物为苯丙氨酸,补阳还五汤及苯丙氨酸均可抑制NLRP3炎症小体激活的作用,且作用相当。结论:补阳还五汤具有延缓高脂饮食诱导的ApoE-/-小鼠AS斑块形成的作用,抑制斑块内巨噬细胞浸润及其NLRP3炎症小体激活是补阳还五汤抑制炎症进而抗AS的重要机制。并可调控动脉粥样硬化模型的代谢紊乱以增加苯丙氨酸的含量,而本研究发现该必需氨基酸恰恰是补阳还五汤抑制巨噬细胞NLRP3炎症小体预激活及活化的关键功能代谢产物。
基于R-Ras/Rac1通路多环节串扰募集周细胞探讨益气活血方药心脑血脉宁抑制斑块内出血的机制
-
批准号:81573733
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2015
-
负责人:姜希娟
-
依托单位:
基于周细胞募集探讨心脑血脉宁促进动脉粥样斑块内新生血管成熟的机制
-
批准号:81102699
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:姜希娟
-
依托单位:
国内基金
海外基金